cyclophosphamide-prednisone is a minimally toxic regimen effective in the treatment of nlpdl , but copp , in view of its acceptable toxicity in this patient population and apparent superiority in providing a longer disease-free state , deserves further testing .
C0280003
cyclophosphamide-prednisone
C0010583
copp